1. Home
  2. POET vs HRTX Comparison

POET vs HRTX Comparison

Compare POET & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • POET
  • HRTX
  • Stock Information
  • Founded
  • POET 1972
  • HRTX 1983
  • Country
  • POET Canada
  • HRTX United States
  • Employees
  • POET N/A
  • HRTX N/A
  • Industry
  • POET Semiconductors
  • HRTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • POET Technology
  • HRTX Health Care
  • Exchange
  • POET Nasdaq
  • HRTX Nasdaq
  • Market Cap
  • POET 369.0M
  • HRTX 325.0M
  • IPO Year
  • POET N/A
  • HRTX 1987
  • Fundamental
  • Price
  • POET $4.34
  • HRTX $1.88
  • Analyst Decision
  • POET Strong Buy
  • HRTX Strong Buy
  • Analyst Count
  • POET 2
  • HRTX 2
  • Target Price
  • POET $6.25
  • HRTX $5.50
  • AVG Volume (30 Days)
  • POET 728.7K
  • HRTX 2.1M
  • Earning Date
  • POET 05-14-2025
  • HRTX 05-06-2025
  • Dividend Yield
  • POET N/A
  • HRTX N/A
  • EPS Growth
  • POET N/A
  • HRTX N/A
  • EPS
  • POET N/A
  • HRTX N/A
  • Revenue
  • POET $199,477.00
  • HRTX $148,518,000.00
  • Revenue This Year
  • POET $9,379.33
  • HRTX $12.60
  • Revenue Next Year
  • POET $684.42
  • HRTX $13.66
  • P/E Ratio
  • POET N/A
  • HRTX N/A
  • Revenue Growth
  • POET N/A
  • HRTX 12.43
  • 52 Week Low
  • POET $1.65
  • HRTX $1.04
  • 52 Week High
  • POET $7.79
  • HRTX $3.93
  • Technical
  • Relative Strength Index (RSI)
  • POET 49.84
  • HRTX 44.20
  • Support Level
  • POET $4.31
  • HRTX $1.82
  • Resistance Level
  • POET $4.68
  • HRTX $1.93
  • Average True Range (ATR)
  • POET 0.25
  • HRTX 0.11
  • MACD
  • POET -0.04
  • HRTX -0.01
  • Stochastic Oscillator
  • POET 28.03
  • HRTX 36.73

About POET POET Technologies Inc.

POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.

About HRTX Heron Therapeutics Inc.

Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.

Share on Social Networks: